Business
MyndTec Inc. Completes Eighth Tranche of Non-Brokered Private Placement
Mississauga, Ontario--(Newsfile Corp. - December 3, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a neurological treatment and rehabilitation medical technology company, is pleased to announce that it has closed the eighth tranche of its non-brokered private placement previously announced on January 30, 2025 (the "Offering"). The eighth tranche of the private placement consists of 351,475 Units of the Company (the "Units") at a price of $0.20 per Unit for aggregate gross...
About this update from Myndtec, Inc.
[{"type":"text","content":"Mississauga, Ontario--(Newsfile Corp. - December 3, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a neurological treatment and rehabilitation medical technology company, is pleased to announce that it has closed the eighth tranche of its non-brokered private placement previously announced on January 30, 2025 (the "Offering"). The eighth tranche of the private placement consists of 351,475 Units of the Company (the "Units") at a price of $0.20 per Unit for aggregate gross proceeds to the Company of $70,295 (the "Eighth Tranche"). The completion of the Eighth Tranche brings the aggregate Units issued to date under the Offering to 4,163,978 for aggregate gross proceeds under the Offering to $832,824.60.","length":781,"tagName":"p"},{"type":"text","content":"Each Unit is comprised of one common share (each, a "Common Share") in the capital of the Company and one half (1/2) Common Share purchase warrant (each, a "Warrant"), whereby each whole Warrant is exercisable to acquire one Common Share (each, a "Warrant Share") at an exercise price of $0.24 per Warrant Share for a period of 36 months following the applicable Closing Date.","length":406,"tagName":"p"},{"type":"text","content":"The Company intends to use the net proceeds of the Eighth Tranche for general corporate purposes, including working capital, corporate development, development of machine learning models, settlement of outstanding debt obligations, investor relations and marketing.","length":265,"tagName":"p"},{"type":"text","content":"In Canada, the Units (and the underlying Common Shares, Warrants and Warrant Shares) are subject to a statutory hold period of four (4) months from the closing date of this tranche. In the United States, the Units (and the underlying Common Shares, Warrants and Warrant Shares) have not and will not be registered under the U.S. Securities Act and are subject to restrictions on transfer that prevent any transfer or resale absent registration or an applicable exemption from the registration requirements under United States federal and state securities laws. Closing of this tranche remains subject to the final acceptance by the Canadian Securities Exchange.","length":661,"tagName":"p"},{"type":"text","content":"Related parties of the Company su...